Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
6.24
-0.20 (-3.11%)
At close: Apr 7, 2026, 4:00 PM EDT
6.32
+0.08 (1.28%)
After-hours: Apr 7, 2026, 4:06 PM EDT
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $11.25 million as of April 7, 2026. Its market cap has increased by 82.54% in one year.
Market Cap
11.25M
Enterprise Value
-4.95M
1-Year Change
82.54%
Ranking
Category
Stock Price
$6.24
Market Cap Chart
Since October 29, 2021, Quoin Pharmaceuticals's market cap has decreased from $97.17M to $11.25M, a decrease of -88.42%. That is a compound annual growth rate of -38.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 11.62M | -4.06% |
| Dec 31, 2025 | 12.11M | 127.24% |
| Dec 31, 2024 | 5.33M | 10.02% |
| Dec 29, 2023 | 4.84M | -29.65% |
| Dec 30, 2022 | 6.88M | -54.69% |
| Dec 31, 2021 | 15.19M | -84.36% |
| Oct 29, 2021 | 97.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imunon | 12.28M |
| Genprex | 12.21M |
| Chemomab Therapeutics | 11.95M |
| CytoMed Therapeutics | 11.70M |
| Soligenix | 11.65M |
| Theriva Biologics | 11.44M |
| Cellectar Biosciences | 11.41M |
| Cadrenal Therapeutics | 11.03M |